Complications have been reported after breast augmentation, lift procedures, and implant-based reconstruction procedures involving mesh or internal bra materials.
These outcomes may include infection, seroma, hematoma, delayed wound healing, capsular contracture, implant malposition, pain, scarring, and revision surgery.
Many of these complications are recognized risks of breast implant and reconstruction procedures generally.
In lawsuits involving breast mesh products, patients allege that mesh materials, product labeling, surgical technique, or incomplete risk disclosures contributed to the severity or persistence of their injuries.
Some patients require additional medical treatment after complications develop, including antibiotics, drainage procedures, debridement, implant removal, mesh removal, or revision surgery.
The role of mesh in these outcomes depends on the patient’s medical history, procedure type, product used, surgeon technique, tissue quality, and postoperative course.
Infection and Abscess Formation
Infection is a recognized complication of breast implant surgery, reconstruction, and revision procedures, including procedures involving mesh or internal bra materials.
In some cases, bacteria may colonize the implant pocket, mesh surface, or surrounding tissue, which can make treatment more difficult.
Patients with postoperative infection may experience swelling, redness, warmth, drainage, fever, non-healing wounds, or worsening pain.
Treatment may involve oral antibiotics, IV antibiotics, drainage, wound care, debridement, or removal of the implant and mesh material when infection cannot be controlled.
Some breast mesh lawsuits cite adverse event reports and medical records involving infections after mesh-assisted breast procedures.
Those reports do not, by themselves, prove that mesh caused the infection, but they may become part of a broader legal review involving product labeling, surgical risks, and whether the patient received adequate warnings before surgery.
One MAUDE adverse event report described a patient hospitalized for an enterococcus faecalis infection linked to a mesh used in breast reconstruction; the patient underwent implant and mesh removal.
Seromas and Chronic Fluid Buildup
Seromas are pockets of fluid that can form after breast surgery, including augmentation, mastectomy reconstruction, revision surgery, and procedures involving mesh or internal support materials.
Fluid buildup may occur when tissue planes are disrupted during surgery and the body produces inflammatory fluid during healing.
Many seromas resolve with observation or drainage.
Persistent or recurrent seromas may require repeated aspiration, drain placement, imaging, antibiotics if infection is suspected, or additional surgery.
When mesh is present, physicians may evaluate whether the fluid collection involves the implant pocket, surrounding scar tissue, or the area where the mesh was placed.
Patients may notice swelling, tightness, visible asymmetry, rippling, tenderness, or a soft lump near the surgical site.
Ultrasound or other imaging may be used to identify the fluid pocket and guide treatment.
In breast mesh litigation, seromas are commonly reviewed as part of the patient’s overall postoperative course.
The legal question is usually not whether seromas can occur after breast surgery, but whether the patient was adequately warned about the risk and whether the product, procedure, or postoperative management contributed to a persistent or severe outcome.
Hematoma and Postoperative Bleeding
Hematoma and postoperative bleeding are recognized complications after breast augmentation, reconstruction, and revision procedures.
A hematoma occurs when blood collects within the surgical pocket, which can increase pressure, pain, swelling, bruising, and the risk of additional wound complications.
In implant-based breast reconstruction with mesh support, a meta-analysis found a hematoma formation rate of approximately 2.5% across several studies.
Breast procedures involving mesh or internal support materials may be reviewed more closely when bleeding leads to implant loss, infection, tissue compromise, or revision surgery.
The presence of mesh does not automatically mean the mesh caused the hematoma.
Bleeding risk can depend on surgical technique, anatomy, medications, clotting history, drain placement, tissue quality, and the extent of dissection.
Treatment may involve observation, compression, imaging, surgical evacuation, or additional procedures to control bleeding and protect the implant pocket.
In lawsuits involving breast mesh, hematoma-related claims often focus on whether the patient was properly informed about possible surgical risks and whether later complications required avoidable revision procedures.
Delayed Wound Healing and Tissue Necrosis
Delayed wound healing and tissue necrosis can occur after breast reconstruction, augmentation, lift procedures, and revision surgeries.
Necrosis develops when skin, fat, or flap tissue does not receive enough blood flow to survive.
Known risk factors may include thin skin flaps, prior radiation, infection, smoking history, diabetes, surgical tension, implant pressure, and compromised tissue quality.
A 2021 review cited wound-healing disorders with necrosis in the mesh group of breast reconstruction patients.
When mesh or an internal bra material is used, physicians may assess whether the mesh became exposed, whether the implant pocket was compromised, and whether removal or revision surgery is necessary.
Mesh placement does not automatically establish the cause of tissue loss, but it may become relevant when a patient develops wound breakdown, exposure, infection, or reconstructive failure.
Patients may experience darkened skin, open wounds, delayed incision closure, drainage, exposed implant material, exposed mesh, or worsening pain.
Severe cases may require debridement, wound care, antibiotics, implant removal, mesh removal, or conversion to another reconstructive approach.
Capsular Contracture and Excessive Scar Formation
Capsular contracture occurs when scar tissue around a breast implant tightens and hardens.
The breast may feel firm, painful, elevated, distorted, or visibly misshapen.
Capsular contracture is a known complication of breast implant surgery, with or without mesh.
Biologic and synthetic mesh products have been used in some reconstruction and revision procedures to support the implant pocket and address scar-related complications.
Published studies have reported varying outcomes depending on the product, procedure type, patient population, follow-up period, and surgical technique.
Studies have found capsular contracture rates in implant-based breast reconstruction patients range between roughly 15% and 30% when no mesh or scaffold is used.
The use of biologic and synthetic mesh (such as ADM or P4HB scaffolds) in reconstruction and cosmetic procedures was introduced with the intention of reducing this risk by stabilizing the pocket and moderating scar response, but there remains mixed and limited long-term data on their effectiveness.
Even when mesh is used, excessive scar formation may still occur: the foreign material can initiate a heightened inflammatory response, encourage myofibroblast activity, and lead to a thickened, contractile capsule around the implant.
Some patients who underwent mesh-assisted procedures still report painful tightening, scar bands, implant displacement, asymmetry, or visible distortion.
Revision surgery may become more complex when scar tissue, implant material, and mesh have integrated into the surgical pocket.
Mesh Migration, Displacement, and Internal “Cording”
Mesh migration or displacement may occur when an implanted support material shifts from its intended position or no longer provides the expected structural support.
Patients may report changes in breast shape, implant position, visible asymmetry, tightness, or palpable bands beneath the skin.
Movement or malposition after breast surgery can have several possible causes, including tissue stretching, implant weight, fixation technique, scar formation, gravity, healing patterns, and revision history.
When mesh was used, physicians may evaluate whether the material remained properly positioned, whether scar tissue formed around it, and whether correction requires revision surgery.
A recent narrative review found that implant displacement, bottoming out, and mesh malposition are among the complications reported in mesh-supported breast surgeries.
Some patients describe internal “cording,” pulling, or tethering sensations after breast procedures.
These symptoms may involve scar tissue, tissue contraction, nerve irritation, or the location of implanted material.
Mesh Extrusion and Tissue Erosion
Mesh extrusion and tissue erosion can occur when tissue covering a breast implant or support material breaks down after surgery, leading to visible exposure of the implant, mesh, or surrounding reconstructive components.
These complications have been reported after implant-based reconstruction procedures, including some involving biologic or synthetic mesh materials.
Tissue breakdown may develop in the setting of infection, wound-healing complications, poor blood supply, skin-flap compromise, radiation exposure, tissue tension, or prior revision surgery.
When exposure occurs, physicians may evaluate whether the implant pocket, surrounding tissue, or implanted support material can be preserved or whether removal is necessary.
Patients experiencing extrusion or erosion may develop drainage, visible implant or mesh exposure, non-healing wounds, redness, pain, thinning skin, or progressive breakdown near the incision line.
Published case reports and reconstructive literature describe situations where implant exposure ultimately required implant removal, mesh removal, wound revision, or conversion to another reconstructive approach.
Some studies discussing internal support materials in breast reconstruction have noted risks such as palpability, exposure, erosion, or biofilm formation involving certain synthetic products.
Outcomes vary depending on the product used, tissue quality, surgical technique, radiation history, infection status, and overall healing conditions.
Reconstruction Failure and Implant Loss
Reconstruction failure and implant loss refer to situations where postoperative complications become severe enough that the breast implant, surrounding reconstructive materials, or associated support structures must be removed.
These outcomes may occur after implant-based breast reconstruction procedures with or without mesh involvement.
Clinical research on implant-based breast reconstruction and acellular dermal matrix (ADM) products commonly track explantation, reoperation, infection, wound complications, and flap-related problems as important postoperative outcomes.
Implant removal may become necessary in cases involving uncontrolled infection, persistent wound breakdown, tissue necrosis, implant exposure, chronic seroma formation, or severe capsular contracture.
FDA communications and published reconstruction literature have discussed differing complication rates reported among certain ADM products used in implant-based reconstruction procedures.
Those findings do not establish that all mesh products are defective or unsafe, but they may be referenced in litigation involving postoperative complications and revision surgery claims.
Broader reviews of immediate implant-based reconstruction consistently identify infection, wound dehiscence, flap compromise, and tissue necrosis as factors associated with reconstructive failure.
In some cases involving implants or mesh materials, persistent bacterial contamination or biofilm formation may make conservative treatment unsuccessful, leading physicians to recommend implant removal or explantation procedures.
Patients who experience reconstruction failure often undergo additional surgeries to remove implants, revise the reconstruction, address scarring or deformity, manage infection, or transition to tissue-based reconstruction methods.
Chronic Pain, Tightness, and Nerve Symptoms
Chronic breast, chest wall, axillary, or arm pain may occur after mastectomy, reconstruction, augmentation, or revision surgery.
Potential causes include nerve injury, scar tissue, muscle spasm, implant position, capsular contracture, inflammation, neuroma formation, or complications involving implanted materials.
One prospective cohort of 213 women undergoing mastectomy or reconstruction found that pain in the upper breast, axilla and arm persisted at year-1 and year-5, with location differing by surgical method.
A systematic review covering over 26,000 patients revealed chronic pain in about 41.8% of mastectomy-only patients and nearly 49.5% of those who had immediate reconstruction.
Some postoperative pain may be neuropathic in nature and can involve nerve injury, neuroma formation, scar tissue, implant position, or other postoperative changes associated with breast surgery.
For example, a case series of women with breast implants found traumatic neuromas in the implant capsules and complete pain resolution after explantation.
Patients who undergo mesh-assisted breast procedures may later report tightness, pulling sensations, chest wall discomfort, or restricted movement following surgery. Potential contributing factors can include scar tissue, implant position, nerve irritation, inflammation, or postoperative healing changes.
Research on post-breast surgery pain syndrome (PBSPS) confirms chest wall, axillary and breast pain can be caused by nerve damage, muscle spasm, and scarring after both oncologic and cosmetic surgeries.
Breast Deformities and Permanent Scarring
Deformities such as rippling, contour irregularities, implant malposition, and visible asymmetry have been reported after implant-based breast reconstruction and augmentation procedures, including some involving mesh or scaffold materials.
Some published reconstruction studies have reported differing aesthetic and capsular contracture outcomes among patient groups undergoing procedures with acellular dermal matrix (ADM) or mesh materials.
Outcomes may vary depending on surgical technique, patient selection, tissue quality, radiation exposure, and follow-up duration.
In some patients, scarring may become thickened, tethered, raised, or cosmetically prominent depending on tissue quality, healing response, radiation exposure, infection, or postoperative complications.
Long-term reconstruction studies involving ADM products have reported revision surgeries related to cosmetic concerns, capsular contracture, asymmetry, implant position changes, and postoperative healing complications.
Complications such as wound breakdown, tissue necrosis, implant exposure, or implant loss may contribute to permanent scarring, contour changes, or reshaping of the reconstructed breast.
Because deformities and scarring often require further corrective surgeries (sometimes multiple) the emotional and functional consequences are substantial.
Revision Surgeries and Long-Term Complications
Revision surgery may become necessary after breast reconstruction, augmentation, or internal bra procedures when patients experience postoperative complications such as pain, implant malposition, capsular contracture, fluid collections, wound-healing problems, or cosmetic deformities.
Additional procedures may be recommended to remove implanted materials, reposition implants, revise scar tissue, treat postoperative complications, or address cosmetic changes that develop after reconstruction or augmentation surgery.
Some patients report ongoing symptoms or cosmetic concerns months or years after reconstruction or augmentation procedures, including pain, tightness, asymmetry, implant-position changes, or recurrent scar-related complications.
These cumulative complications often result in additional operative risks, higher medical costs, and long-lasting physical and emotional burdens.
Long-term postoperative complications reported after breast reconstruction or augmentation procedures, including some involving mesh materials, may include:
- Chronic breast or chest wall pain
- Recurrent seromas or fluid buildup requiring ongoing intervention
- Persistent inflammation or localized immune reactions
- Progressive capsular contracture
- Implant malposition or recurrent ptosis
- Visible deformities or contour irregularities
- Thick, tethered, or hypertrophic scarring
- Loss of breast volume or asymmetry
- Need for conversion to autologous (tissue-based) reconstruction
